AAAAAA

   
Results: 1-11 |
Results: 11
ESTROGEN-RECEPTOR EXPRESSION IS A COMMON FEATURE OF OVARIAN BORDERLINE TUMORS
Authors: ABUJAWDEH GM JACOBS TW NILOFF J CANNISTRA SA
Citation: Gm. Abujawdeh et al., ESTROGEN-RECEPTOR EXPRESSION IS A COMMON FEATURE OF OVARIAN BORDERLINE TUMORS, Gynecologic oncology, 60(2), 1996, pp. 301-307
STRONG EXPRESSION OF VASCULAR-PERMEABILITY FACTOR (VASCULAR ENDOTHELIAL GROWTH-FACTOR) AND ITS RECEPTORS IN OVARIAN BORDERLINE AND MALIGNANT NEOPLASMS
Authors: ABUJAWDEH GM FAIX JD NILOFF J TOGNAZZI K MANSEAU E DVORAK HF BROWN LF
Citation: Gm. Abujawdeh et al., STRONG EXPRESSION OF VASCULAR-PERMEABILITY FACTOR (VASCULAR ENDOTHELIAL GROWTH-FACTOR) AND ITS RECEPTORS IN OVARIAN BORDERLINE AND MALIGNANT NEOPLASMS, Laboratory investigation, 74(6), 1996, pp. 1105-1115
ABSENCE OF CONSTITUTIVE EGF RECEPTOR ACTIVATION IN OVARIAN-CANCER CELL-LINES
Authors: OTTENSMEIER C SWANSON L STROBEL T DRUKER B NILOFF J CANNISTRA SA
Citation: C. Ottensmeier et al., ABSENCE OF CONSTITUTIVE EGF RECEPTOR ACTIVATION IN OVARIAN-CANCER CELL-LINES, British Journal of Cancer, 74(3), 1996, pp. 446-452
ESTABLISHING AN INTERDISCIPLINARY PATIENT-CARE TEAM
Authors: MCHUGH M WEST P ASSATLY C DUPRAT L HOWARD L NILOFF J WALDO K WANDEL J CLIFFORD J
Citation: M. Mchugh et al., ESTABLISHING AN INTERDISCIPLINARY PATIENT-CARE TEAM, The Journal of nursing administration, 26(4), 1996, pp. 21-27
FUNCTIONAL-HETEROGENEITY OF CD44 MOLECULES IN OVARIAN-CANCER CELL-LINES
Authors: CANNISTRA SA DEFRANZO B NILOFF J OTTENSMEIER C
Citation: Sa. Cannistra et al., FUNCTIONAL-HETEROGENEITY OF CD44 MOLECULES IN OVARIAN-CANCER CELL-LINES, Clinical cancer research, 1(3), 1995, pp. 333-342
CD44 VARIANT EXPRESSION IS A COMMON FEATURE OF EPITHELIAL OVARIAN-CANCER - LACK OF ASSOCIATION WITH STANDARD PROGNOSTIC FACTORS
Authors: CANNISTRA SA ABUJAWDEH G NILOFF J STROBEL T SWANSON L ANDERSEN J OTTENSMEIER C
Citation: Sa. Cannistra et al., CD44 VARIANT EXPRESSION IS A COMMON FEATURE OF EPITHELIAL OVARIAN-CANCER - LACK OF ASSOCIATION WITH STANDARD PROGNOSTIC FACTORS, Journal of clinical oncology, 13(8), 1995, pp. 1912-1921
EXPRESSION AND FUNCTION OF BETA-1 AND ALPHA-V-BETA-3 INTEGRINS IN OVARIAN-CANCER
Authors: CANNISTRA SA OTTENSMEIER C NILOFF J ORTA B DICARLO J
Citation: Sa. Cannistra et al., EXPRESSION AND FUNCTION OF BETA-1 AND ALPHA-V-BETA-3 INTEGRINS IN OVARIAN-CANCER, Gynecologic oncology, 58(2), 1995, pp. 216-225
IMMUNOHISTOCHEMICAL EXPRESSION OF ESTROGEN-RECEPTORS IN OVARIAN SEROUS AND MUCINOUS BORDERLINE TUMORS
Authors: JACOBS TW CANNISTRA S NILOFF J ABUJAWDEH GM
Citation: Tw. Jacobs et al., IMMUNOHISTOCHEMICAL EXPRESSION OF ESTROGEN-RECEPTORS IN OVARIAN SEROUS AND MUCINOUS BORDERLINE TUMORS, Laboratory investigation, 72(1), 1995, pp. 91-91
DISCRIMINATION OF NORMAL FROM PRECANCEROUS EXFOLIATED CERVICAL CELLS BY ANTIBODIES TO NUCLEAR MATRIX PROTEINS
Authors: LENTRICHIA B HUTCHINSON M MEYER J SHEETS E NILOFF J LIDGARD G
Citation: B. Lentrichia et al., DISCRIMINATION OF NORMAL FROM PRECANCEROUS EXFOLIATED CERVICAL CELLS BY ANTIBODIES TO NUCLEAR MATRIX PROTEINS, Laboratory investigation, 70(1), 1994, pp. 10000039-10000039
USE OF PERIPHERAL-BLOOD PROGENITOR CELLS ABROGATES THE MYELOTOXICITY OF REPETITIVE OUTPATIENT HIGH-DOSE CARBOPLATIN AND CYCLOPHOSPHAMIDE CHEMOTHERAPY
Authors: TEPLER I CANNISTRA SA FREI E GONIN R ANDERSON KC DEMETRI G NILOFF J GOODMAN H MUNTZ H MUTO M SHEETS E ELIAS AD MAZANET R WHEELER C AYASH L SCHWARTZ G MCCAULEY M GAYNES L HARVEY S SCHNIPPER LE ANTMAN KH
Citation: I. Tepler et al., USE OF PERIPHERAL-BLOOD PROGENITOR CELLS ABROGATES THE MYELOTOXICITY OF REPETITIVE OUTPATIENT HIGH-DOSE CARBOPLATIN AND CYCLOPHOSPHAMIDE CHEMOTHERAPY, Journal of clinical oncology, 11(8), 1993, pp. 1583-1591
BINDING OF OVARIAN-CANCER CELLS TO PERITONEAL MESOTHELIUM IN-VITRO ISPARTLY MEDIATED BY CD44H
Authors: CANNISTRA SA KANSAS GS NILOFF J DEFRANZO B KIM Y OTTENSMEIER C
Citation: Sa. Cannistra et al., BINDING OF OVARIAN-CANCER CELLS TO PERITONEAL MESOTHELIUM IN-VITRO ISPARTLY MEDIATED BY CD44H, Cancer research, 53(16), 1993, pp. 3830-3838
Risultati: 1-11 |